GLPwatch
Trials (2139)
Page 14 of 36.
- Effects of Semaglutide in HIV-Associated Lipohypertrophy
- Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Liraglutide Treatment in Obese Infertile PCOS Women
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- Separate and Combined Extrapancreatic Effects of GIP and GLP-1
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
- Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
- 24-h Energy Expenditure and Anti-obesity Medication
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
- 16-week Flexible vs. 8-week Semaglutide Titration
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
- A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
- A Phase I Study of LY3502970 in Healthy Participants
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
- Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
- A Study of BGM0504 in Participants With Obesity
- A Study to Evaluate ALN-2232 in Participants With Obesity
- Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
- Study of Patients Being Treated With Anti-obesity Medication
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Specific Clinical Experience Investigation for Long-term Use of Bydureon.
- Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
- Semaglutide for Low Back Pain
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- GLP1R in Parkinson's Disease
- Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
- Trial of EXenatide in Acute Ischaemic Stroke
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease